The Osteoporosis Prevention and Arterial effects of tiboLone (OPAL) study: design and baseline characteristics (Q44684635)

5 December 2017

The Osteoporosis Prevention and Arterial effects of tiboLone (OPAL) study: design and baseline characteristics (English)

1 reference

5 December 2017

0 references

8

Diederick E Grobbee

1 reference

5 December 2017

6

Electra D Paskett

1 reference

5 December 2017

4

Rudy Meijer

1 reference

5 December 2017

1

Michiel L Bots

1 reference

5 December 2017

Gregory W Evans

2

1 reference

5 December 2017

Ward Riley

3

1 reference

5 December 2017

Karen H McBride

5

1 reference

5 December 2017

Frans A Helmond

7

1 reference

5 December 2017

OPAL Investigators

9

1 reference

5 December 2017

language of work or name

English

0 references

publication date

1 December 2003

1 reference

Contemporary Clinical Trials

5 December 2017

1 reference

5 December 2017

24

1 reference

5 December 2017

6

1 reference

5 December 2017

752-775

1 reference

The primary prevention of coronary heart disease in women

5 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

Cardiovascular disease in women: a statement for healthcare professionals from the American Heart Association. Writing Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

Effects of hormone replacement therapy on serum lipids in elderly women. a randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

Hormone replacement therapy and endothelial function: the exception that proves the rule?

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

Hormone replacement therapy and endothelial function. Results of a randomized controlled trial in healthy postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

Estrogen replacement and brachial artery flow-mediated vasodilation in older women.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

Associations of postmenopausal estrogen use with cardiovascular disease and its risk factors in older women. The CHS Collaborative Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

Hormone replacement therapy and intima-media thickness of the common carotid artery: the Rotterdam study

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

Association of hormone replacement therapy and carotid wall thickness in women with and without diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

No association of menopause and hormone replacement therapy with carotid artery intima-media thickness. Atherosclerosis Risk in Communities (ARIC) Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

Carotid artery wall thickness in women treated with hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

The effect of hormone replacement therapy on carotid arteries: measurement with a high frequency ultrasound system

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

Hormone replacement therapy in postmenopausal women protects against smoking-induced changes in vascular structure and function

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

A case-control study of myocardial infarction in relation to use of estrogen supplements.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

A study of the association between hormone replacement therapy, smoking and the occurrence of myocardial infarction in women

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

Long-term survival after coronary heart disease. Comparisons between men and women in a national sample

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

Estrogen replacement therapy and prognosis after first myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

Postmenopausal Estrogen and Progestin Use and the Risk of Cardiovascular Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

Reduced mortality associated with long-term postmenopausal estrogen therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

Postmenopausal hormone therapy and mortality.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

Estrogen replacement therapy after coronary angioplasty in women

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

Estrogen replacement therapy and outcome of coronary balloon angioplasty in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

Effect on survival of estrogen replacement therapy after coronary artery bypass grafting

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

Hormone replacement therapy and incidence of acute myocardial infarction. A population-based nested case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

Hormone therapy and in-hospital survival after myocardial infarction in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

Risk of recurrent coronary events in relation to use and recent initiation of postmenopausal hormone therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

Trends in the incidence of coronary heart disease and changes in diet and lifestyle in women

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

Cardioprotective effect of hormone replacement therapy in postmenopausal women: is the evidence biased?

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

Effects of estrogen replacement on the progression of coronary-artery atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

Low-dose contraceptive estrogen-progestin and coronary artery atherosclerosis of monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

Regression of atherosclerosis in female monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

Medroxyprogesterone acetate antagonizes inhibitory effects of conjugated equine estrogens on coronary artery atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

Hormone replacement therapy in perimenopausal women and 2-year change of carotid intima-media thickness

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

Effect of oral postmenopausal hormone replacement on progression of atherosclerosis : a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

Increased common carotid intima-media thickness. Adaptive response or a reflection of atherosclerosis? Findings from the Rotterdam Study

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

Circulating cell adhesion molecules are correlated with ultrasound-based assessment of carotid atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

Carotid wall thickness is predictive of incident clinical stroke: the Atherosclerosis Risk in Communities (ARIC) study

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

Carotid intima-media thickness in Japanese type 2 diabetic subjects: predictors of progression and relationship with incident coronary heart disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

Prognostic implications of intima-media thickness and plaques in the carotid and femoral arteries in patients with stable angina pectoris

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

Is carotid intima-media thickness useful in cardiovascular disease risk assessment? The Rotterdam Study

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

Beneficial effects of colestipol-niacin therapy on the common carotid artery. Two- and four-year reduction of intima-media thickness measured by ultrasound

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

One-year reduction and longitudinal analysis of carotid intima-media thickness associated with colestipol/niacin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

Kuopio Atherosclerosis Prevention Study (KAPS). A population-based primary preventive trial of the effect of LDL lowering on atherosclerotic progression in carotid and femoral arteries.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

Effect of pravastatin on progression and regression of coronary atherosclerosis and vessel wall changes in carotid and femoral arteries: a report from the Regression Growth Evaluation Statin Study

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

Final outcome results of the Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS). A randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

Pravastatin reduces carotid intima-media thickness progression in an asymptomatic hypercholesterolemic mediterranean population: the Carotid Atherosclerosis Italian Ultrasound Study

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

Progression of atherosclerosis in middle-aged men: effects of multifactorial intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

Effects of lowering average of below-average cholesterol levels on the progression of carotid atherosclerosis: results of the LIPID Atherosclerosis Substudy. LIPID Trial Research Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) study: a randomized trial of the effect of vitamins E and C on 3-year progression of carotid atherosclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. PREVENT Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

Randomized, placebo-controlled trial of the angiotensin-converting enzyme inhibitor, ramipril, in patients with coronary or other occlusive arterial disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

Low-dose metoprolol CR/XL and fluvastatin slow progression of carotid intima-media thickness: Main results from the Beta-Blocker Cholesterol-Lowering Asymptomatic Plaque Study (BCAPS).

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

Differential effects of nifedipine and co-amilozide on the progression of early carotid wall changes

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

Baseline reproducibility of B-mode ultrasonic measurement of carotid artery intima-media thickness: the European Lacidipine Study on Atherosclerosis (ELSA).

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

Design and rationale of the ARBITER trial (Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol)--a randomized trial comparing the effects of atorvastatin and pravastatin on carotid artery intima-media thickness

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

1 reference

7 January 2021

A comparison of tibolone and conjugated equine estrogens effects on coronary artery atherosclerosis and bone density of postmenopausal monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

Lowering of HDL cholesterol in post-menopausal women by tibolone is not associated with changes in cholesterol efflux capacity or paraoxonase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

Comparison of the antiatherosclerotic effect of tibolone with that of estradiol and ethinyl estradiol in cholesterol-fed, ovariectomized rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

Tibolone prevents atherosclerotic lesion formation in cholesterol-fed, ovariectomized rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

Estrogen replacement therapy and progression of intimal-medial thickness in the carotid arteries of postmenopausal women. ACAPS Investigators. Asymptomatic Carotid Atherosclerosis Progression Study

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

Analysis strategies for serial multivariate ultrasonographic data that are incomplete

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

Reliability of longitudinal ultrasonographic measurements of carotid intimal-medial thicknesses. Asymptomatic Carotid Artery Progression Study Research Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

Carotid intima-media wall thickness in elderly women with and without atherosclerosis of the abdominal aorta

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

Common carotid intima-media thickness and lower extremity arterial atherosclerosis. The Rotterdam Study

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

Relationship between carotid intima-media thickness and symptomatic and asymptomatic peripheral arterial disease. The Edinburgh Artery Study

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

Increased carotid intimal-medial thickness and coronary calcification are related in young and middle-aged adults. The Muscatine study

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

Correlations between vascular calcification and atherosclerosis: a comparative electron beam CT study of the coronary and carotid arteries

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

Coronary calcification detected by electron-beam computed tomography and myocardial infarction. The Rotterdam Coronary Calcification Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

The carotid intima-media thickness as a marker of the presence of severe symptomatic coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

Association of coronary disease with segment-specific intimal-medial thickening of the extracranial carotid artery.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

Carotid intima-media thickness is only weakly correlated with the extent and severity of coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

Intimal medial thickening of common carotid artery as indicator of coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

Atherosclerotic changes in the carotid artery bulb as measured by B-mode ultrasound are associated with the extent of coronary atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

Relation of coronary artery disease to atherosclerotic disease in the aorta, carotid, and femoral arteries evaluated by ultrasound

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

Comparison of peripheral endothelial dysfunction and intimal media thickness in patients with suspected coronary artery disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

Atherosclerotic changes of extracoronary arteries are associated with the extent of coronary atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

Usefulness of carotid intima-media thickness measurement and peripheral B-mode ultrasound scan in the clinical screening of patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

Correlations between measures of atherosclerosis change using carotid ultrasonography and coronary angiography

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

Effects of lovastatin and warfarin on early carotid atherosclerosis: sex-specific analyses. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

Plasma Homocysteine in Women Taking Hormone Replacement Therapy: The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Study

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

Effect of postmenopausal hormone therapy on lipoprotein(a) concentration. PEPI Investigators. Postmenopausal Estrogen/Progestin Interventions

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

The heart and estrogen/progestin replacement study revisited: hormone replacement therapy produced net harm, consistent with the observational data

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

Postmenopausal hormone use and secondary prevention of coronary events in the nurses' health study. a prospective, observational study

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

Hormone replacement therapy, prothrombotic mutations, and the risk of incident nonfatal myocardial infarction in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900096-5

7 January 2021

10.1016/S0197-2456(03)00096-5

Identifiers

DOI

1 reference

5 December 2017

1 reference